Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Problems Associated with Deprescribing of Proton Pump Inhibitors
Hólmfríður Helgadóttir, Einar S. Björnsson
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5469-5469
Open Access | Times Cited: 80

Showing 26-50 of 80 citing articles:

Deprescribing of proton pump inhibitors in older patients: A cost-effectiveness analysis
M. Xie, Joyce H. S. You
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0311658-e0311658
Open Access | Times Cited: 2
Activating Transcription Factor 3 Protects against Restraint Stress-Induced Gastrointestinal Injury in Mice
Dun-Jie Chuang, Subhashree Pethaperumal, Bijaya Siwakoti, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3530-3530
Open Access | Times Cited: 16
The impact of deprescribing interventions on oral proton pump inhibitor utilisation in a Singapore tertiary hospital: A quality improvement initiative
Christina Tan, Shi Xun Lee, Tat Ming Ng
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 1, pp. 8-15
Open Access | Times Cited: 10
Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae
Senyo Tagboto
American Journal of Case Reports (2022) Vol. 23
Open Access | Times Cited: 10
Effect of frequently prescribed drugs on gastric cancer risk
Theresa Weltermann, Christian Schulz, Lukas Macke
Best Practice & Research Clinical Gastroenterology (2021) Vol. 50-51, pp. 101741-101741
Closed Access | Times Cited: 13
Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors
Beth Zerr, Alejandro Vázquez, Brian L. Erstad
American Journal of Health-System Pharmacy (2023) Vol. 80, Iss. 15, pp. 967-973
Closed Access | Times Cited: 5
De-Prescribing Proton Pump Inhibitors in Patients With End Stage Kidney Disease: A Quality Improvement Project
Daniel Czikk, Yasin Parpia, Katelyn Roberts, et al.
Canadian Journal of Kidney Health and Disease (2022) Vol. 9
Open Access | Times Cited: 8
Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse
Edoardo Savarino, Foteini Anastasiou, Joachim Labenz, et al.
British Journal of General Practice (2022) Vol. 72, Iss. 724, pp. 541-544
Open Access | Times Cited: 8
A free ride: Is long‐term omeprazole therapy safe and effective?
B. W. Sykes
Equine Veterinary Education (2021) Vol. 33, Iss. 10, pp. 556-560
Closed Access | Times Cited: 11
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project
Lamuela L. J. Calvo, P. Camara, Mónica Llorente Barrio, et al.
European Journal of Clinical Pharmacology (2021) Vol. 77, Iss. 12, pp. 1927-1933
Closed Access | Times Cited: 11
Efficacy of an oral suspension containing xyloglucan and pea proteins on a murine model of gastroesophageal reflux disease
Alessio Ardizzone, Deborah Mannino, Giovanna Casili, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1610-1622
Open Access | Times Cited: 1
A narrative review on rebound acid hypersecretion due to long-term use of proton pump inhibitors
Vysheshika Balivada, Ruttuja Mayuraysh Koraykar
Annals of the National Academy of Medical Sciences (India) (2024) Vol. 60, pp. 113-119
Open Access | Times Cited: 1
Implications of the Updated Lyon Consensus 2.0 in Clinical Practice
Mako Koseki, Emily S Seltzer, Kimberly Cavaliere, et al.
Foregut The Journal of the American Foregut Society (2024)
Closed Access | Times Cited: 1
The Gastric Connection: Serum Gastric Biomarkers, Metabolic Syndrome and Transition in Metabolic Status
Yuexiang Qin, Shanhu Yao, Gaoyuan Wang, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 6439-6452
Open Access | Times Cited: 1
Chakras’ Energies Alterations in Patients with Chronic Gastritis
Huang Wei Ling
Gastroenterology Open Access Open Journal (2020) Vol. I, Iss. 1, pp. 20-23
Open Access | Times Cited: 10
Proton pump inhibitors: misconceptions and proper prescribing practice
Mitchell L. Schubert
Current Opinion in Gastroenterology (2020) Vol. 36, Iss. 6, pp. 493-500
Closed Access | Times Cited: 9
Efficacy of a computer based discontinuation strategy to reduce PPI prescriptions: a multicenter cluster-randomized controlled trial
Julia Heisig, Bettina Bücker, Alexandra Schmidt, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer
Darina Kohoutová, Matthew Banks, Jan Bureš
Cancers (2021) Vol. 13, Iss. 24, pp. 6242-6242
Open Access | Times Cited: 8
REVISE: re-evaluating the inhibition of stress erosions in the ICU—statistical analysis plan for a randomized trial
Diane Heels‐Ansdell, Laurent Billot, Lehana Thabane, et al.
Trials (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Addressing long-term PPI safety
Carmelo Scarpignato, Salvatore Tolone
Digestive and Liver Disease (2020) Vol. 52, Iss. 8, pp. 853-856
Closed Access | Times Cited: 8
Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa
Atsushi Tatsuguchi, Shintaro Hoshino, Noriyuki Kawami, et al.
Pathology - Research and Practice (2020) Vol. 216, Iss. 10, pp. 153113-153113
Open Access | Times Cited: 8
Understanding the Patient PPI Journey: Results of a Survey on PPI Treatment Initiation and Patient Experience
Kate Plehhova, Natalie M. Paquette, James L. Gould, et al.
Journal of Primary Care & Community Health (2022) Vol. 13
Open Access | Times Cited: 5
Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength
Md. Saddam Hussain, Tanoy Mazumder
Journal of Basic and Clinical Physiology and Pharmacology (2021) Vol. 33, Iss. 5, pp. 567-579
Closed Access | Times Cited: 6
The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD)
Ahmed Almarhabi, Ahmed M. Hashem, Bader Faiyaz Zuberi, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 3, pp. 217-233
Open Access | Times Cited: 4
Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week)
В. Т. Ивашкин, И. В. Маев, А. С. Трухманов, et al.
Russian Journal of Gastroenterology Hepatology Coloproctology (2020) Vol. 30, Iss. 6, pp. 7-18
Open Access | Times Cited: 5

Scroll to top